{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:31Z","timestamp":1786119571803,"version":"build-2736575974"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/med.0b013e328325d155","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T01:55:41Z","timestamp":1294970141000},"page":"125-131","source":"Crossref","is-referenced-by-count":45,"title":["Bone metabolism in type 2 diabetes and role of thiazolidinediones"],"prefix":"10.1097","volume":"16","author":[{"given":"Peter","family":"Vestergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20211004","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00198-004-1680-8","article-title":"Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark","volume":"16","author":"Vestergaard","year":"2005","journal-title":"Osteoporos Int"},{"key":"R3-7-20211004","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","article-title":"Body mass index as a predictor of fracture risk: a meta-analysis","volume":"16","author":"De Laet","year":"2005","journal-title":"Osteoporos Int"},{"key":"R4-7-20211004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","article-title":"Smoking and fracture risk: a meta-analysis","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"R5-7-20211004","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","article-title":"Alcohol intake as a risk factor for fracture","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"R6-7-20211004","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bone.2004.06.017","article-title":"A family history of fracture and fracture risk: a meta-analysis","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"R7-7-20211004","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"R8-7-20211004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R9-7-20211004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00001648-199401000-00008","article-title":"Racial differences in fracture risk","volume":"5","author":"Baron","year":"1994","journal-title":"Epidemiology"},{"key":"R10-7-20211004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"R11-7-20211004","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R12-7-20211004","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/acta.0.0900463","article-title":"Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis","volume":"90","author":"McNair","year":"1979","journal-title":"Acta Endocrinol"},{"key":"R13-7-20211004","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01235883","article-title":"Bone loss in diabetes: effects of metabolic state","volume":"17","author":"McNair","year":"1979","journal-title":"Diabetologia"},{"key":"R14-7-20211004","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","article-title":"High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group","volume":"354","author":"Cappuccio","year":"1999","journal-title":"Lancet"},{"key":"R15-7-20211004","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/cs0710239","article-title":"Altered extracellular calcium homoeostasis in essential hypertension: a consequence of abnormal cell calcium handling","volume":"71","author":"Strazzullo","year":"1986","journal-title":"Clin Sci (Lond)"},{"key":"R16-7-20211004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/acta.0.0960081","article-title":"Hypoparathyroidism in diabetes mellitus","volume":"96","author":"McNair","year":"1981","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R17-7-20211004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02556109","article-title":"Diabetic bone disease [editorial]","volume":"49","author":"Bouillon","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"R18-7-20211004","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00365518209168118","article-title":"Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D","volume":"42","author":"Christiansen","year":"1982","journal-title":"Scand J Clin Lab Invest"},{"key":"R19-7-20211004","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"key":"R20-7-20211004","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/ATVBAHA.108.165886","article-title":"Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004","volume":"28","author":"Melamed","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-7-20211004","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/(SICI)1096-9136(199712)14:12<1038::AID-DIA509>3.0.CO;2-1","article-title":"Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients","volume":"14","author":"Clausen","year":"1997","journal-title":"Diabet Med"},{"key":"R22-7-20211004","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(81)92447-8","article-title":"Is diabetic osteoporosis due to microangiopathy?","volume":"1","author":"McNair","year":"1981","journal-title":"Lancet"},{"key":"R23-7-20211004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2337\/diacare.22.5.827","article-title":"Impact of peripheral neuropathy on bone density in patients with type 1 diabetes","volume":"22","author":"Rix","year":"1999","journal-title":"Diabetes Care"},{"key":"R24-7-20211004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00223-002-2070-x","article-title":"Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women","volume":"73","author":"Tanko","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"R25-7-20211004","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1359\/jbmr.1997.12.2.283","article-title":"Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures","volume":"12","author":"Vogt","year":"1997","journal-title":"J Bone Miner Res"},{"key":"R26-7-20211004","first-page":"387","article-title":"Forearm endothelial function and bone mineral loss in postmenopausal women.","volume":"176","author":"Sanada","year":"2004","journal-title":""},{"key":"R27-7-20211004","first-page":"7","article-title":"Histomorphometric analysis of the bone tissue in patients with noninsulin-dependent diabetes (DMNID)","volume":"51","author":"Leite Duarte","year":"1996","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"R28-7-20211004","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1210\/jc.2002-021447","article-title":"Octreotide abolishes the acute decrease in bone turnover in response to oral glucose","volume":"88","author":"Clowes","year":"2003","journal-title":"J Clin Endocrinol Metabol"},{"key":"R29-7-20211004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00223-003-0069-6","article-title":"Improving metabolic control reverses the histomorphometric and biomechanical abnormalities of an experimentally induced bone deficit in spontaneously diabetic rats","volume":"74","author":"Follak","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"R30-7-20211004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"R31-7-20211004","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"R32-7-20211004","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1210\/endo-123-1-290","article-title":"Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling","volume":"123","author":"Glajchen","year":"1988","journal-title":"Endocrinology"},{"key":"R33-7-20211004","first-page":"129","article-title":"Serum osteocalcin and diabetes mellitus. A study of 98 patients","volume":"83","author":"Cantini","year":"1992","journal-title":"Minerva Med"},{"key":"R34-7-20211004","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/BF00265373","article-title":"Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications","volume":"31","author":"Pietschmann","year":"1988","journal-title":"Diabetologia"},{"key":"R35-7-20211004","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10067-004-1070-9","article-title":"Bone metabolism in male patients with type 2 diabetes","volume":"24","author":"Achemlal","year":"2005","journal-title":"Clin Rheumatol"},{"key":"R36-7-20211004","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/BF00301944","article-title":"Increasing serum osteocalcin after glycemic control in diabetic men","volume":"57","author":"Sayinalp","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"R37-7-20211004","first-page":"323","article-title":"Serum osteocalcin levels in type I diabetes mellitus","volume":"37","author":"Pasaoglu","year":"1995","journal-title":"Turk J Pediatr"},{"key":"R38-7-20211004","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000244259","article-title":"Umbilical cord osteocalcin in normal pregnancies and pregnancies complicated by fetal growth retardation or diabetes mellitus","volume":"68","author":"Verhaeghe","year":"1995","journal-title":"Biol Neonate"},{"key":"R39-7-20211004","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00198-006-0087-0","article-title":"Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture","volume":"17","author":"Saito","year":"2006","journal-title":"Osteoporos Int"},{"key":"R40-7-20211004","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.mehy.2005.07.017","article-title":"Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients","volume":"65","author":"Yamagishi","year":"2005","journal-title":"Med Hypotheses"},{"key":"R41-7-20211004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/ard.2004.034348","article-title":"Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings","volume":"65","author":"Hein","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R42-7-20211004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00198-005-2035-9","article-title":"The role of collagen in bone strength","volume":"17","author":"Viguet-Carrin","year":"2006","journal-title":"Osteoporos Int"},{"key":"R43-7-20211004","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/rheumatology\/keg324","article-title":"Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis","volume":"42","author":"Hein","year":"2003","journal-title":"Rheumatol (Oxf)"},{"key":"R44-7-20211004","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1196\/annals.1333.082","article-title":"Advanced glycation end products and bone loss during aging","volume":"1043","author":"Odetti","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R45-7-20211004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.V82260","article-title":"Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles","volume":"8","author":"Miyata","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 5","key":"R46-7-20211004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ndt\/11.supp5.54","article-title":"Possible involvement of advanced glycation end-products in bone resorption","volume":"11","author":"Miyata","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R47-7-20211004","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1074\/jbc.M610536200","article-title":"Nonenzymatic glycation of bone collagen modifies osteoclastic activity and differentiation","volume":"282","author":"Valcourt","year":"2007","journal-title":"J Biol Chem"},{"key":"R48-7-20211004","first-page":"E655","article-title":"Circulating insulin levels are related to bone density in normal postmenopausal women","volume":"265","author":"Reid","year":"1993","journal-title":"Am J Physiol"},{"key":"R49-7-20211004","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"R50-7-20211004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s002230020018","article-title":"Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice","volume":"69","author":"Tornvig","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"R51-7-20211004","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1359\/jbmr.1998.13.3.371","article-title":"Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders","volume":"13","author":"Nuttall","year":"1998","journal-title":"J Bone Mineral Res"},{"key":"R52-7-20211004","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/endo.143.6.8834","article-title":"Divergent effects of selective peroxisome proliferator-activated receptor-gamma ligands on adipocyte versus osteoblast differentiation","volume":"143","author":"Lecka-Czernik","year":"2002","journal-title":"Endocrinology"},{"key":"R53-7-20211004","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"R54-7-20211004","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1210\/en.2006-1121","article-title":"Activation of peroxisome proliferator-activated receptor gamma (PPAR gamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo","volume":"148","author":"Lecka-Czernik","year":"2007","journal-title":"Endocrinology"},{"key":"R55-7-20211004","first-page":"1604","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy","volume":"60","author":"Rubin","year":"2005","journal-title":"Cancer Res"},{"key":"R56-7-20211004","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1210\/en.2006-1587","article-title":"Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone","volume":"148","author":"Lazarenko","year":"2007","journal-title":"Endocrinology"},{"key":"R57-7-20211004","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/joe.1.05723","article-title":"Rosiglitazone impacts negatively on bone by promoting osteoblast\/osteocyte apoptosis","volume":"183","author":"Soroceanu","year":"2004","journal-title":"J Endocrinol"},{"key":"R58-7-20211004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/en.2003-0746","article-title":"Bone is a target for the antidiabetic compound rosiglitazone","volume":"145","author":"Rzonca","year":"2004","journal-title":"Endocrinology"},{"key":"R59-7-20211004","doi-asserted-by":"crossref","first-page":"RC26","DOI":"10.1007\/BF03350807","article-title":"Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells.","volume":"30","author":"Benvenuti","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"R60-7-20211004","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm1672","article-title":"PPAR-gamma regulates osteoclastogenesis in mice","volume":"13","author":"Wan","year":"2007","journal-title":"Nat Med"},{"key":"R61-7-20211004","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1210\/jc.2007-0431","article-title":"Rosiglitazone decreases serum bone specific alkaline phosphatase activity in postmenopausal diabetic women","volume":"92","author":"Berberoglu","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R62-7-20211004","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","article-title":"The peroxisome-proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomised controlled trial","volume":"92","author":"Grey","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-7-20211004","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults","volume":"91","author":"Schwartz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-7-20211004","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dc06-2606","article-title":"Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men","volume":"30","author":"Yaturu","year":"2007","journal-title":"Diabetes Care"},{"key":"R65-7-20211004","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"R66-7-20211004","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archinte.168.8.820","article-title":"Use of thiazolidinediones and fracture risk","volume":"168","author":"Meier","year":"2008","journal-title":"Arch Intern Med"},{"key":"R67-7-20211004","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"R68-7-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JCD:7:1:1","article-title":"Official positions of the International Society for Clinical Densitometry","volume":"7","author":"Leib","year":"2004","journal-title":"J Clin Densitom"},{"key":"R69-7-20211004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-5122(01)00240-7","article-title":"Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women","volume":"40","author":"Vestergaard","year":"2001","journal-title":"Maturitas"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-200904000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:53:16Z","timestamp":1786042396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-200904000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e328325d155","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}